Institute of Neuroscience and Physiology,
Department of Psychiatry and Neurochemistry,
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Kaj Blennow has not added Biography.
If you are Kaj Blennow and would like to personalize this page please email our Author Liaison for assistance.
Evidence that the gene encoding insulin degrading enzyme influences human lifespan.
Human molecular genetics Aug, 2008 | Pubmed ID: 18448515
Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Neuroscience letters Feb, 2009 | Pubmed ID: 19022350
Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.
Journal of Alzheimer's disease : JAD , 2009 | Pubmed ID: 19158416
A survey of ABCA1 sequence variation confirms association with dementia.
Human mutation Sep, 2009 | Pubmed ID: 19606474
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
JAMA Jul, 2009 | Pubmed ID: 19622817
Sustained release of neuron-specific enolase to serum in amateur boxers.
Brain injury Aug, 2009 | Pubmed ID: 19636997
Sequence variation in SORL1 and dementia risk in Swedes.
Neurogenetics Feb, 2010 | Pubmed ID: 19653016
Amyloid beta and APP as biomarkers for Alzheimer's disease.
Experimental gerontology Jan, 2010 | Pubmed ID: 19698775
Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.
Experimental neurology Jun, 2010 | Pubmed ID: 19815015
Total and phosphorylated tau protein as biological markers of Alzheimer's disease.
Experimental gerontology Jan, 2010 | Pubmed ID: 19853650
Subcortical vascular dementia biomarker pattern in mild cognitive impairment.
Dementia and geriatric cognitive disorders , 2009 | Pubmed ID: 19864909
CSF biomarkers: pinpointing Alzheimer pathogenesis.
Annals of the New York Academy of Sciences Oct, 2009 | Pubmed ID: 19906258
Kinesin light chain 1 gene haplotypes in three conformational diseases.
Neuromolecular medicine Sep, 2010 | Pubmed ID: 19911314
Converging molecular pathways in human neural development and degeneration.
Neuroscience research Mar, 2010 | Pubmed ID: 19961883
Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
Mechanisms of ageing and development Feb, 2010 | Pubmed ID: 20064547
Is there a CSF biomarker profile related to depression in elderly women?
Psychiatry research Apr, 2010 | Pubmed ID: 20132991
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.
Molecular neurodegeneration Jan, 2010 | Pubmed ID: 20145736
Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.
Human molecular genetics May, 2010 | Pubmed ID: 20167577
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
BMC medical genetics Mar, 2010 | Pubmed ID: 20196834
Biochemical markers in Alzheimer's disease clinical trials.
Biomarkers in medicine Feb, 2010 | Pubmed ID: 20387305
Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
Alzheimer's research & therapy Apr, 2010 | Pubmed ID: 20441609
Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs.
Journal of Alzheimer's disease : JAD , 2010 | Pubmed ID: 20634579
Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.
Cerebrospinal fluid research Jul, 2010 | Pubmed ID: 20673341
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people.
Archives of neurology Aug, 2010 | Pubmed ID: 20697045
Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease.
International journal of Alzheimer's disease Jul, 2010 | Pubmed ID: 20721354
Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.
International journal of Alzheimer's disease Jul, 2010 | Pubmed ID: 20798852
Pleiotropy in the presence of allelic heterogeneity: alternative genetic models for the influence of APOE on serum LDL, CSF amyloid-β42, and dementia.
Journal of Alzheimer's disease : JAD , 2010 | Pubmed ID: 20847432
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.
Brain research Nov, 2010 | Pubmed ID: 20875798
Biomarkers in Alzheimer's disease drug development.
Nature medicine Nov, 2010 | Pubmed ID: 21052077
Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease.
Alzheimer's research & therapy Nov, 2010 | Pubmed ID: 21122172
Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.
Journal of Alzheimer's disease : JAD , 2011 | Pubmed ID: 21157031
Genetic association of sequence variants near AGER/NOTCH4 and dementia.
Journal of Alzheimer's disease : JAD , 2011 | Pubmed ID: 21297263
Cerebrospinal fluid analysis should be considered in patients with cognitive problems.
International journal of Alzheimer's disease Jul, 2010 | Pubmed ID: 21487447
Biomarker-based dissection of neurodegenerative diseases.
Progress in neurobiology Dec, 2011 | Pubmed ID: 21524681
Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method.
Neurochemical research Nov, 2011 | Pubmed ID: 21674238
Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease.
Journal of Alzheimer's disease : JAD , 2011 | Pubmed ID: 21860087
Biomarkers for microglial activation in Alzheimer's disease.
International journal of Alzheimer's disease , 2011 | Pubmed ID: 22114747
CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma.
PloS one , 2012 | Pubmed ID: 22496755
An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid.
Journal of mass spectrometry : JMS May, 2012 | Pubmed ID: 22576872
CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.
PloS one , 2012 | Pubmed ID: 22701578
Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?
Journal of Alzheimer's disease : JAD , 2013 | Pubmed ID: 22710917
Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
PloS one , 2012 | Pubmed ID: 22880031
Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers.
Biomarkers in medicine Aug, 2012 | Pubmed ID: 22917142
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
Biomarkers in medicine Aug, 2012 | Pubmed ID: 22917143
Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.
Dementia and geriatric cognitive disorders , 2012 | Pubmed ID: 22922641
Fluid biomarkers in Alzheimer disease.
Cold Spring Harbor perspectives in medicine Sep, 2012 | Pubmed ID: 22951438
Serum levels of LIGHT in MS.
Multiple sclerosis (Houndmills, Basingstoke, England) Jun, 2013 | Pubmed ID: 23037546
The neuropathology and neurobiology of traumatic brain injury.
Neuron Dec, 2012 | Pubmed ID: 23217738
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application.
Alzheimer's research & therapy , 2013 | Pubmed ID: 23286718
Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
Brain research Jun, 2013 | Pubmed ID: 23541617
Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers.
Nature reviews. Neurology Apr, 2013 | Pubmed ID: 23558985
The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.
The Medical clinics of North America May, 2013 | Pubmed ID: 23642576
Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.
PloS one , 2013 | Pubmed ID: 23799095
Cerebrospinal fluid biomarkers in cardiac arrest survivors.
Resuscitation Feb, 2014 | Pubmed ID: 24231570
CSF Presenilin-1 complexes are increased in Alzheimer's disease.
Acta neuropathologica communications Aug, 2013 | Pubmed ID: 24252417
Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers.
PloS one , 2013 | Pubmed ID: 24260563
Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infections.
Clinical biochemistry Jan, 2014 | Pubmed ID: 24275252
[Exercise and weight loss does not reduce cardiovascular risk in type 2 diabetes].
Lakartidningen Jan 15-28, 2014 | Pubmed ID: 24552015
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?
Alzheimer's & dementia : the journal of the Alzheimer's Association Nov, 2014 | Pubmed ID: 24721526
CSF Aβ42 predicts early-onset dementia in Parkinson disease.
Neurology May, 2014 | Pubmed ID: 24748671
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Apr, 2015 | Pubmed ID: 24751826
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Jan, 2015 | Pubmed ID: 24795085
Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.
Clinical chemistry Jul, 2014 | Pubmed ID: 24842955
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
The Lancet. Neurology Jun, 2014 | Pubmed ID: 24849862
Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample.
Brain, behavior, and immunity Oct, 2014 | Pubmed ID: 24858658
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
Alzheimer's research & therapy , 2014 | Pubmed ID: 24987465
Tau, s-100 calcium-binding protein B, and neuron-specific enolase as biomarkers of concussion-reply.
JAMA neurology Jul, 2014 | Pubmed ID: 25023557
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
Dementia and geriatric cognitive disorders extra May, 2014 | Pubmed ID: 25298777
Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 25420549
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.
Nature reviews. Neurology Jan, 2015 | Pubmed ID: 25511894
Rarity of the Alzheimer disease-protective APP A673T variant in the United States.
JAMA neurology Feb, 2015 | Pubmed ID: 25531812
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Oct, 2015 | Pubmed ID: 25533203
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.
Alzheimer's & dementia : the journal of the Alzheimer's Association Nov, 2015 | Pubmed ID: 25804998
Amyloid biomarkers in Alzheimer's disease.
Trends in pharmacological sciences May, 2015 | Pubmed ID: 25840462
Serum visinin-like protein-1 in concussed professional ice hockey players.
Brain injury , 2015 | Pubmed ID: 25955117
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
JAMA May, 2015 | Pubmed ID: 25988462
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
Brain : a journal of neurology Sep, 2015 | Pubmed ID: 26220940
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.
JAMA neurology Oct, 2015 | Pubmed ID: 26258692
Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26401701
Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26401784
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26402100
Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.
Journal of neurology Dec, 2015 | Pubmed ID: 26410752
Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26444757
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.
Neuroscience letters Nov, 2015 | Pubmed ID: 26453765
The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events.
Frontiers in neuroscience , 2015 | Pubmed ID: 26483625
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases.
Frontiers in neurology , 2015 | Pubmed ID: 26528237
Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid.
Alzheimer's & dementia : the journal of the Alzheimer's Association May, 2016 | Pubmed ID: 26555316
Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction.
Anesthesiology Feb, 2016 | Pubmed ID: 26580833
Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot study.
Diving and hyperbaric medicine Dec, 2015 | Pubmed ID: 26687311
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment.
Alzheimer's research & therapy , 2015 | Pubmed ID: 26689589
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.
Alzheimer's research & therapy , 2015 | Pubmed ID: 26698298
Serum Neurofilament Light in American Football Athletes over the Course of a Season.
Journal of neurotrauma Oct, 2016 | Pubmed ID: 26700106
HNK-1 Carrier Glycoproteins Are Decreased in the Alzheimer's Disease Brain.
Molecular neurobiology Jan, 2017 | Pubmed ID: 26738850
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
Molecular neurodegeneration , 2016 | Pubmed ID: 26754172
Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football.
Medicine and science in sports and exercise Jun, 2016 | Pubmed ID: 26765633
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
Scientific reports , 2016 | Pubmed ID: 26856756
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
Journal of neuroimmunology Mar, 2016 | Pubmed ID: 26943959
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
Nature communications , 2016 | Pubmed ID: 26948379
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.
Alzheimer's research & therapy , 2016 | Pubmed ID: 26948580
Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women.
Obesity (Silver Spring, Md.) Jun, 2016 | Pubmed ID: 27130070
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.
Movement disorders : official journal of the Movement Disorder Society Jun, 2016 | Pubmed ID: 27145480
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.
Clinica chimica acta; international journal of clinical chemistry May, 2016 | Pubmed ID: 27216941
Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.
Stroke; a journal of cerebral circulation Jul, 2016 | Pubmed ID: 27301948
Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving.
Brain injury , 2016 | Pubmed ID: 27389622
Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
Journal of neurovirology Jul, 2016 | Pubmed ID: 27400930
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.
EMBO molecular medicine Oct, 2016 | Pubmed ID: 27534871
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.
Journal of neurochemistry Aug, 2016 | Pubmed ID: 27579672
Specific Triazine Herbicides Induce Amyloid-β42 Production.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27589520
Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27589532
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease.
Proteomics. Clinical applications Sep, 2016 | Pubmed ID: 27604409
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.
Molecular neurodegeneration , 2016 | Pubmed ID: 27605218
Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease.
Dementia and geriatric cognitive disorders Sep, 2016 | Pubmed ID: 27643858
Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury.
JAMA neurology Sep, 2016 | Pubmed ID: 27654934
Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27662296
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 27662307
Plasma tau in Alzheimer disease.
Neurology Sep, 2016 | Pubmed ID: 27694257
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
Journal of neurochemistry Oct, 2016 | Pubmed ID: 27787906
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 27792012
CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults.
Neurobiology of aging Jan, 2017 | Pubmed ID: 27794264
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury.
Scientific reports Nov, 2016 | Pubmed ID: 27819296
Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.
JAMA neurology Jan, 2017 | Pubmed ID: 27842175
Traumatic brain injuries.
Nature reviews. Disease primers 11, 2016 | Pubmed ID: 27853132
Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 27858714
The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 27911308
Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease.
Scientific reports Dec, 2016 | Pubmed ID: 27929120
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism.
Acta neuropathologica Dec, 2016 | Pubmed ID: 27933404
Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.
ACS chemical neuroscience Feb, 2017 | Pubmed ID: 27984697
Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders.
European archives of psychiatry and clinical neuroscience Dec, 2016 | Pubmed ID: 28039552
Expanding the cerebrospinal fluid endopeptidome.
Proteomics Mar, 2017 | Pubmed ID: 28044435
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28059783
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28059797
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.
Neurobiology of aging Mar, 2017 | Pubmed ID: 28061383
Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Jan, 2017 | Pubmed ID: 28073031
Genome-wide association study identifies MAPT locus influencing human plasma tau levels.
Neurology Feb, 2017 | Pubmed ID: 28100725
Neurofilament Protein and Antineurofilament Antibodies Following Traumatic Brain Injury-Reply.
JAMA neurology Mar, 2017 | Pubmed ID: 28135356
Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay.
Clinical chemistry and laboratory medicine Feb, 2017 | Pubmed ID: 28160541
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Neurology Mar, 2017 | Pubmed ID: 28179466
The effects of different familial Alzheimer's disease mutations on APP processing in vivo.
Alzheimer's research & therapy Feb, 2017 | Pubmed ID: 28209190
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers.
Alzheimer's & dementia : the journal of the Alzheimer's Association Feb, 2017 | Pubmed ID: 28216393
Ex vivo (18)O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway.
Molecular neurodegeneration Feb, 2017 | Pubmed ID: 28219449
Author response: Calcium supplementation and risk of dementia in women with cerebrovascular disease.
Neurology Feb, 2017 | Pubmed ID: 28220015
Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
PloS one , 2017 | Pubmed ID: 28241046
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
Acta neuropathologica Feb, 2017 | Pubmed ID: 28247064
The immune response of the human brain to abdominal surgery.
Annals of neurology Mar, 2017 | Pubmed ID: 28253549
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Mar, 2017 | Pubmed ID: 28263742
Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.
Journal of Alzheimer's disease : JAD Feb, 2017 | Pubmed ID: 28269767
Astroglial activation and altered amyloid metabolism in human repetitive concussion.
Neurology Mar, 2017 | Pubmed ID: 28283595
Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease.
Stem cell reports Mar, 2017 | Pubmed ID: 28285880
Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging.
PloS one , 2017 | Pubmed ID: 28291839
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
Neurobiology of aging Apr, 2017 | Pubmed ID: 28317649
Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports.
Neurology May, 2017 | Pubmed ID: 28404801
Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28505968
A Season of American Football Is Not Associated with Changes in Plasma Tau.
Journal of neurotrauma Aug, 2017 | Pubmed ID: 28614998
Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study.
Scientific reports Jun, 2017 | Pubmed ID: 28615661
Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy.
Cerebral cortex (New York, N.Y. : 1991) Jun, 2017 | Pubmed ID: 28655157
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls.
Journal of neural transmission (Vienna, Austria : 1996) Jun, 2017 | Pubmed ID: 28656371
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28697566
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.
The Lancet. Neurology Aug, 2017 | Pubmed ID: 28721928
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood.
Neurology and therapy Jul, 2017 | Pubmed ID: 28733960
Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28826187
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders.
Proteomics. Clinical applications Oct, 2017 | Pubmed ID: 28972305
Serum tau and neurological outcome in cardiac arrest.
Annals of neurology Nov, 2017 | Pubmed ID: 28981963
A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.
Proteomics. Clinical applications Oct, 2017 | Pubmed ID: 29028155
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.
Scientific reports Oct, 2017 | Pubmed ID: 29074982
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial.
The Lancet. Neurology Oct, 2017 | Pubmed ID: 29097166
Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ.
Molecular and cellular neurosciences Dec, 2017 | Pubmed ID: 29104140
Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly: A Longitudinal Study.
American journal of respiratory and critical care medicine Nov, 2017 | Pubmed ID: 29125327
Central and Peripheral Leptin and Agouti-Related Protein during and after Pregnancy in Relation to Weight Change.
Clinical endocrinology Nov, 2017 | Pubmed ID: 29154467
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유